Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. - Wikidata - awgldk - TriplyDB

Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.

Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.

http://www.wikidata.org/entity/Q38646074

about

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies.Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently from p53 status.Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.Critical molecular pathways in CLL therapy.Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib Educational Case: Chronic Lymphocytic Leukemia Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia

P2860

Q48199074-4D27A414-2820-4C36-93F2-D3BF9718093B Q52323624-CCE2DE45-8F99-40C5-90DE-21CF315CBB1F Q52576558-DA6471AE-7B4A-44A7-BE16-0FDD235A9F48 Q52641879-B210D4B3-99C5-4AAF-A466-CF8AC0FC38DD Q52727954-052A8434-28B4-40B9-A505-937DEC9B7E9E Q55283747-484A483D-6A24-48E4-A2CC-22455AB7B9E3 Q55447785-F1C80E48-BF36-473C-AB78-54E7B29E1AFB Q55453510-81C7D417-5636-4BBC-B7A9-58C211D9F509 Q55668973-60956309-A063-4454-9D9D-EEB651BA85AD Q58729853-53BE2C15-0D45-48B3-91E0-5D518FCE0AC4 Q58782131-11337BCF-8A61-4270-8404-5286BBF54F75 Q58805876-7881FF82-34B6-45CD-A793-AE75D03383C8 Q59137780-C80B9FF9-CD99-499E-BB7C-317DC8090FCE Q59137904-CDF407FF-FB9F-4286-9023-0B50583CC480

P2860

Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.

http://www.wikidata.org/entity/Q38646074

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chronic lymphocytic leukemia: ...... stratification, and treatment.

@en

type

label

Chronic lymphocytic leukemia: ...... stratification, and treatment.

@en

prefLabel

Chronic lymphocytic leukemia: ...... stratification, and treatment.

@en

P1433

Q38646074-20724649-C2FB-4954-A3EE-3C14190D00C5

P1476

Q38646074-AE8A6BDD-6BC0-402A-92AA-ACAB0BF1C445

P2860

Q38646074-01D60044-5DFB-4B2F-AD26-39D6903C36ED

Q38646074-034C5A99-CBED-4AE8-B28A-5A9F46D37B48

Q38646074-03FF8C93-6C0B-42A1-9922-9A888F9B9633

Q38646074-068CA9F4-CB13-4392-B4BE-DCF5C77CA4B0

Q38646074-07F781A5-F1B3-4C06-B78C-73A00D459071

Q38646074-08CE285D-705E-4DE5-9CF2-C72D081CC8D7

Q38646074-0D01BCA7-5B9C-4ABE-8E52-612DA4DFA073

Q38646074-0D38333C-B3F8-49CF-84DF-513E011ED24F

Q38646074-0DF6D9A1-89DE-4622-ABD9-CD4AB3572E3E

Q38646074-12B1966C-0901-47A3-9269-CD07F5296525

P304

Q38646074-5B85F45E-CD44-47AA-96E7-C98EEA906F2E

P31

Q38646074-54B8AA5D-1917-4E19-8318-A3F7F737FBD9

P356

Q38646074-32DC8F40-4B66-4B39-A14F-9487EAB0EB06

P433

Q38646074-5CECEC76-FBA1-493E-B5C0-3F4C8FF091D6

P478

Q38646074-0DA218BD-AB09-47A2-95CE-77F4A3D22E10

P50

Q38646074-301F7660-318A-4018-AD5D-72F561B93CB7

P577

Q38646074-8479523D-1D4F-4DED-8FC6-9D9DA19B3400

P698

Q38646074-993A628E-2A34-477E-87D0-E92B7DA2E271

P921

Q38646074-5E8E1B84-2378-4B40-945A-5E639B16119C

P356

P1433

American Journal of Hematology

P1476

Chronic lymphocytic leukemia: ...... stratification, and treatment.

@en

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

The DNA-damage response in human biology and disease

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

P304

946-965

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24826

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28782884

http://www.w3.org/2001/XMLSchema#string

P921